Redox-manipulating nanocarriers for anticancer drug delivery: a systematic review

Xian‐Kai Meng; Yongli Shen; Huanyu Zhao; Xinlei Lu; Zheng Wang; Yanjun Zhao

doi:10.1186/s12951-024-02859-w

journal article Open Access Sep 28, 2024

Redox-manipulating nanocarriers for anticancer drug delivery: a systematic review

Xian‐Kai Meng Yongli Shen Huanyu Zhao

Xinlei Lu Zheng Wang

Yanjun Zhao

Journal of Nanobiotechnology Vol. 22 No. 1 · Springer Science and Business Media LLC

View at Publisher Save 10.1186/s12951-024-02859-w

Topics

No keywords indexed for this article. Browse by subject →

References

169

[1]

Sun T, Jiang C. Stimuli-responsive drug delivery systems triggered by intracellular or subcellular microenvironments. Adv Drug Deliv Rev. 2023;196:114773. https://doi.org/10.1016/j.addr.2023.114773. 10.1016/j.addr.2023.114773

[2]

Devnarain N, Osman N, Fasiku VO, Makhathini S, Salih M, Ibrahim UH, Govender T. Intrinsic stimuli-responsive nanocarriers for smart drug delivery of antibacterial agents-An in-depth review of the last two decades. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2021;13(1):e1664. https://doi.org/10.1002/wnan.1664. 10.1002/wnan.1664

[3]

Yi X, Zeng W, Wang C, Chen Y, Zheng L, Zhu X, Ke Y, He X, Kuang Y, Huang Q. A step-by-step multiple stimuli-responsive metal-phenolic network prodrug nanoparticles for chemotherapy. Nano Res. 2022;15:1205–12. https://doi.org/10.1007/s12274-021-3626-2. 10.1007/s12274-021-3626-2

[4]

Fu S, Rempson CM, Puche V, Zhao B, Zhang F. Construction of disulfide containing redox-responsive polymeric nanomedicine. Methods. 2022;199:67–79. https://doi.org/10.1016/j.ymeth.2021.12.011. 10.1016/j.ymeth.2021.12.011

[5]

Gisbert-Garzarán M, Vallet-Regí M. Redox-responsive mesoporous silica nanoparticles for cancer treatment: recent updates. Nanomaterials. 2021;11(9):2222. https://doi.org/10.3390/nano11092222. 10.3390/nano11092222

[6]

Guo X, Cheng Y, Zhao X, Luo Y, Chen J, Yuan W. Advances in redox-responsive drug delivery systems of tumor microenvironment. J Nanobiotechnol. 2018;16:74. https://doi.org/10.1186/s12951-018-0398-2. 10.1186/s12951-018-0398-2

[7]

Mollazadeh S, Mackiewicz M, Yazdimamaghani M. Recent advances in the redox-responsive drug delivery nanoplatforms: a chemical structure and physical property perspective. Mater Sci Eng C Mater Biol Appl. 2021;118:111536. https://doi.org/10.1016/j.msec.2020.111536. 10.1016/j.msec.2020.111536

[8]

Hsu PH, Almutairi A. Recent progress of redox-responsive polymeric nanomaterials for controlled release. J Mater Chem B. 2021;9(9):2179–88. https://doi.org/10.1039/d0tb02190c. 10.1039/d0tb02190c

[9]

Chen M, Liu D, Liu F, Wu Y, Peng X, Song F. Recent advances of redox-responsive nanoplatforms for tumor theranostics. J Control Release. 2021;332:269–84. https://doi.org/10.1016/j.jconrel.2021.02.030. 10.1016/j.jconrel.2021.02.030

[10]

Banstola A, Poudel K, Kim JO, Jeong JH, Yook S. Recent progress in stimuli-responsive nanosystems for inducing immunogenic cell death. J Control Release. 2021;337:505–20. https://doi.org/10.1016/j.jconrel.2021.07.038. 10.1016/j.jconrel.2021.07.038

[11]

Karaosmanoglu S, Zhou M, Shi B, Zhang X, Williams GR, Chen X. Carrier-free nanodrugs for safe and effective cancer treatment. J Control Release. 2021;329:805–32. https://doi.org/10.1016/j.jconrel.2020.10.014. 10.1016/j.jconrel.2020.10.014

[12]

Kou L, Jiang X, Huang H, Lin X, Zhang Y, Yao Q, Chen R. The role of transporters in cancer redox homeostasis and cross-talk with nanomedicines. Asian J Pharm Sci. 2020;15(2):145–57. https://doi.org/10.1016/j.ajps.2020.02.001. 10.1016/j.ajps.2020.02.001

[13]

Long H, Cheng Y, Zhou Z, Luo H, Wen D, Gao L. The key roles of organelles and ferroptosis in Alzheimer’s disease. J Neurosci Res. 2022;100(6):1257–80. https://doi.org/10.1002/jnr.25033. 10.1002/jnr.25033

[14]

Nanocatalytic Theranostics with Glutathione Depletion and Enhanced Reactive Oxygen Species Generation for Efficient Cancer Therapy

Lian‐Hua Fu, Yu Wan, Chao Qi et al.

Advanced Materials 2021 10.1002/adma.202006892

[15]

Kessel D, Jeffers R, Fowlkes JB, Cain C. Effects of sonodynamic and photodynamic treatment on cellular thiol levels. J Photochem Photobiol B. 1996;32(1–2):103–6. https://doi.org/10.1016/1011-1344(95)07196-2. 10.1016/1011-1344(95)07196-2

[16]

Wang S, Li F, Qiao R, Hu X, Liao H, Chen L, Wu J, Wu H, Zhao M, Liu J, et al. Arginine-rich manganese silicate nanobubbles as a ferroptosis-inducing agent for tumor-targeted theranostics. ACS Nano. 2018;12(12):12380–92. https://doi.org/10.1021/acsnano.8b06399. 10.1021/acsnano.8b06399

[17]

Lin L, Song J, Song L, Ke K, Liu Y, Zhou Z, Shen Z, Li J, Yang Z, Tang W, et al. Simultaneous fenton-like ion delivery and glutathione depletion by MnO2-based nanoagent to enhance chemodynamic therapy. Angew Chem Int Ed Engl. 2018;57(18):4902–6. https://doi.org/10.1002/anie.201712027. 10.1002/anie.201712027

[18]

Meng X, Deng J, Liu F, Guo T, Liu M, Dai P, Fan A, Wang Z, Zhao Y. Triggered all-active metal organic framework: ferroptosis machinery contributes to the apoptotic photodynamic antitumor therapy. Nano Lett. 2019;19(11):7866–76. https://doi.org/10.1021/acs.nanolett.9b02904. 10.1021/acs.nanolett.9b02904

[19]

Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death

Scott J. Dixon, Kathryn M. Lemberg, Michael R. Lamprecht et al.

Cell 2012 10.1016/j.cell.2012.03.042

[20]

Feng H, Stockwell BR. Unsolved mysteries. How does lipid peroxidation cause ferroptosis? PLoS Biol. 2018;16(5):e2006203. https://doi.org/10.1371/journal.pbio.2006203. 10.1371/journal.pbio.2006203

[21]

Agmon E, Solon J, Bassereau P, Stockwell BR. Modeling the effects of lipid peroxidation during ferroptosis on membrane properties. Sci Rep. 2018;8:5155. https://doi.org/10.1038/s41598-018-23408-0. 10.1038/s41598-018-23408-0

[22]

Abdalkader M, Lampinen R, Kanninen KM, Malm TM, Liddell JR. Targeting Nrf2 to suppress ferroptosis and mitochondrial dysfunction in neurodegeneration. Front Neurosci. 2018;12:466. https://doi.org/10.3389/fnins.2018.00466. 10.3389/fnins.2018.00466

[23]

Liu M, Liu B, Liu Q, Du K, Wang Z, He N. Nanomaterial-induced ferroptosis for cancer specific therapy. Coord Chem Rev. 2019;382:160–80. https://doi.org/10.1016/j.ccr.2018.12.015. 10.1016/j.ccr.2018.12.015

[24]

An Y, Zhu J, Liu F, Deng J, Meng X, Liu G, Wu H, Fan A, Wang Z, Zhao Y. Boosting the ferroptotic antitumor efficacy via site-specific amplification of tailored lipid peroxidation. ACS Appl Mater Interfaces. 2019;11(33):29655–66. https://doi.org/10.1021/acsami.9b10954. 10.1021/acsami.9b10954

[25]

Tsvetkov P, Coy S, Petrova B, Dreishpoon M, Verma A, Abdusamad M, Rossen J, Joesch-Cohen L, Humeidi R, Spangler RD, et al. Copper induces cell death by targeting lipoylated TCA cycle proteins. Science. 2022;375(6586):1254–61. https://doi.org/10.1126/science.abq4855. 10.1126/science.abq4855

[26]

Han L, Zhang X, Wang Y, Li X, Yang X, Huang M, Hu K, Li L, Wei Y. Redox-responsive theranostic nanoplatforms based on inorganic nanomaterials. J Control Release. 2017;259:40–52. https://doi.org/10.1016/j.jconrel.2017.03.018. 10.1016/j.jconrel.2017.03.018

[27]

Li Y, Feng S, Dai P, Liu F, Shang Y, Yang Q, Qin J, Yuchi Z, Wang Z, Zhao Y. Tailored trojan horse nanocarriers for enhanced redox-responsive drug delivery. J Control Release. 2022;342:201–9. https://doi.org/10.1016/j.jconrel.2022.01.006. 10.1016/j.jconrel.2022.01.006

[28]

Riber CF, Smith AA, Zelikin AN. Self-immolative linkers literally bridge disulfide chemistry and the realm of thiol-free drugs. Adv Healthc Mater. 2015;4(12):1887–90. https://doi.org/10.1002/adhm.201500344. 10.1002/adhm.201500344

[29]

Deng Z, Hu J, Liu S. Disulfide-based self-immolative linkers and functional bioconjugates for biological applications. Macromol Rapid Commun. 2020;41(1):e1900531. https://doi.org/10.1002/marc.201900531. 10.1002/marc.201900531

[30]

Meng X, Gao M, Deng J, Lu D, Fan A, Ding D, Kong D, Wang Z, Zhao Y. Self-immolative micellar drug delivery: the linker matters. Nano Res. 2018;11(12):6177–89. https://doi.org/10.1007/s12274-018-2134-5. 10.1007/s12274-018-2134-5

[31]

Đud M, Tichotová M, Procházková E, Baszczyňski O. Phosphate-based self-immolative linkers for the delivery of amine-containing drugs. Molecules. 2021;26(17):5160. https://doi.org/10.3390/molecules26175160. 10.3390/molecules26175160

[32]

Gonzaga RV, do Nascimento LA, Santos SS, Machado Sanches BA, Giarolla J, Ferreira EI. Perspectives about self-immolative drug delivery systems. J Pharm Sci. 2020;109(11):3262–81. https://doi.org/10.1016/j.xphs.2020.08.014. 10.1016/j.xphs.2020.08.014

[33]

Strategies to Address Low Drug Solubility in Discovery and Development

Hywel D. Williams, Natalie L. Trevaskis, Susan A. Charman et al.

Pharmacological Reviews 2013 10.1124/pr.112.005660

[34]

Gradishar WJ. Albumin-bound paclitaxel: a next-generation taxane. Expert Opin Pharmacother. 2006;7:1041–53. https://doi.org/10.1517/14656566.7.8.1041. 10.1517/14656566.7.8.1041

[35]

Yokaichiya F, Franco MKKD, Araújo DRd, Paula ED, Cavalcanti L. X-ray scattering techniques applied in the development of drug delivery systems. X-ray Scattering. 2017;135 – 56. https://doi.org/10.5772/65326 10.5772/65326

[36]

Torchilin VP. Drug targeting. Eur J Pharm Sci. 2000;11:S81–91. https://doi.org/10.1016/s0928-0987(00)00166-4. 10.1016/s0928-0987(00)00166-4

[37]

Costa SA, Mozhdehi D, Dzuricky MJ, Isaacs FJ, Brustad EM, Chilkoti A. Active targeting of cancer cells by nanobody decorated polypeptide micelle with bio-orthogonally conjugated drug. Nano Lett. 2019;19(1):247–54. https://doi.org/10.1021/acs.nanolett.8b03837. 10.1021/acs.nanolett.8b03837

[38]

Wicki A, Witzigmann D, Balasubramanian V, Huwyler J. Nanomedicine in cancer therapy: challenges, opportunities, and clinical applications. J Control Release. 2015;200:138–57. https://doi.org/10.1016/j.jconrel.2014.12.030. 10.1016/j.jconrel.2014.12.030

[39]

Wang M, Zhai Y, Ye H, Lv Q, Sun B, Luo C, Jiang Q, Zhang H, Xu Y, Jing Y, et al. High co-loading capacity and stimuli-responsive release based on cascade reaction of self-destructive polymer for improved chemo-photodynamic therapy. ACS Nano. 2019;13(6):7010–23. https://doi.org/10.1021/acsnano.9b02096. 10.1021/acsnano.9b02096

[40]

Zhu A, Miao K, Deng Y, Ke H, He H, Yang T, Guo M, Li Y, Guo Z, Wang Y, et al. Dually pH/reduction-responsive vesicles for ultrahigh-contrast fluorescence imaging and thermo-chemotherapy-synergized tumor ablation. ACS Nano. 2015;9:7874–85. https://doi.org/10.1021/acsnano.5b02843. 10.1021/acsnano.5b02843

[41]

Fu J, Chen T, Wang M, Yang N, Li S, Wang Y, Liu X. Acid and alkaline dual stimuli-responsive mechanized hollow mesoporous silica nanoparticles as smart nanocontainers for intelligent anticorrosion coatings. ACS Nano. 2013;7(12):11397–408. https://doi.org/10.1021/nn4053233. 10.1021/nn4053233

[42]

Cancer nanomedicine: progress, challenges and opportunities

Jinjun Shi, Philip W. Kantoff, Richard Wooster et al.

Nature Reviews Cancer 2017 10.1038/nrc.2016.108

[43]

Li X, Wen H, Dong H, Xue W, Pauletti GM, Cai X, Xia W, Shi D, Li Y. Self-assembling nanomicelles of a novel camptothecin prodrug engineered with a redox-responsive release mechanism. Chem Commun (Camb). 2011;47(30):8647–9. https://doi.org/10.1039/c1cc12495a. 10.1039/c1cc12495a

[44]

Swetha KL, Paul M, Maravajjala KS, Kumbham S, Biswas S, Roy A. Overcoming drug resistance with a docetaxel and disulfiram loaded pH-sensitive nanoparticle. J Control Release. 2023;356:93–114. https://doi.org/10.1016/j.jconrel.2023.02.023. 10.1016/j.jconrel.2023.02.023

[45]

Huwyler J, Cerletti A, Fricker G, Eberle AN, Drewe J. By-passing of P-glycoprotein using immunoliposomes. J Drug Target. 2002;10(1):73–9. https://doi.org/10.1080/10611860290007559. 10.1080/10611860290007559

[46]

Richards DA, Maruani A, Chudasama V. Antibody fragments as nanoparticle targeting ligands: a step in the right direction. Chem Sci. 2017;8(1):63–77. https://doi.org/10.1039/c6sc02403c. 10.1039/c6sc02403c

[47]

Jia H, Zhang F, Zhu C, Sun J, Xie X. Amino-grafted water-soluble ferrimagnetic iron oxide nanoparticles with ultra-high relaxivity for dual-modal magnetic resonance imaging. Colloid Surf A-Physicochem Eng Asp. 2023;679:132594. https://doi.org/10.1016/j.colsurfa.2023.132594. 10.1016/j.colsurfa.2023.132594

[48]

Quantum Dots for Live Cells, in Vivo Imaging, and Diagnostics

X. Michalet, F. F. Pinaud, L. A. Bentolila et al.

Science 2005 10.1126/science.1104274

[49]

Dykman L, Khlebtsov N. Gold nanoparticles in biomedical applications: recent advances and perspectives. Chem Soc Rev. 2012;41(6):2256–82. https://doi.org/10.1039/c1cs15166e. 10.1039/c1cs15166e

[50]

Bianco A, Kostarelos K, Prato M. Applications of carbon nanotubes in drug delivery. Curr Opin Chem Biol. 2005;9(6):674–9. https://doi.org/10.1016/j.cbpa.2005.10.005. 10.1016/j.cbpa.2005.10.005

Showing 50 of 169 references

Cited By

110

Stimuli-responsive, prodrug-activating enzyme-functionalized metal-organic frameworks for cancer therapy and tumor microenvironment modulation

Seyyed Mojtaba Mousavi, Masoomeh Yari Kalashgrani · 2026

Coordination Chemistry Reviews

Harnessing Antioxidants in Cancer Therapy: Opportunities, Challenges, and Future Directions

Yu’e Liu, Guangzhen Wu · 2025

Antioxidants

Nano-Phytomedicine: Harnessing Plant-Derived Phytochemicals in Nanocarriers for Targeted Human Health Applications

Nargish Parvin, Mohammad Aslam · 2025

Molecules

Advances in metal-organic framework-based drug delivery systems

M.T. Khulood, U.S. Jijith · 2025

International Journal of Pharmaceut...

Interaction of ferroptosis and cuproptosis in the perspective of pulmonary hypertension

Yan Yang, Lu Liang · 2025

Frontiers in Cardiovascular Medicin...

Metrics

110

Citations

169

References

Details

Published: Sep 28, 2024
Vol/Issue: 22(1)
License: View

Authors

X

Xian‐Kai Meng

School of Mechanical Engineering Jiangsu University 212013 Zhenjiang China

Qinghai University

Funding

National Natural Science Foundation of China Award: 22105145

Tianjin Municipal Nature Science Foundation Award: 23JCQNJC01100

Cite This Article

Xian‐Kai Meng, Yongli Shen, Huanyu Zhao, et al. (2024). Redox-manipulating nanocarriers for anticancer drug delivery: a systematic review. Journal of Nanobiotechnology, 22(1). https://doi.org/10.1186/s12951-024-02859-w

Redox-manipulating nanocarriers for anticancer drug delivery: a systematic review

You May Also Like